About 3 results found for searched term "668-49-5" (0.132 seconds)
Cat.No. | Name | Target |
---|---|---|
M20884 | RG3039 | DNA/RNA Synthesis |
PF-06687859, PF 6687859, Quinazoline 495 | ||
RG3039 (PF-06687859, PF 6687859, Quinazoline 495) is an orally bioavailable and brain-penetrant inhibitor of the mRNA decapping enzyme DcpS with IC50 of 4.2 nM and IC90 of 40 nM, respectively. | ||
M39096 | Murideoxycholic acid | Metabolite/Endogenous Metabolite |
Murideoxycholic acid is a 6 beta-hydroxylated bile acid. | ||
M28505 | PF-06685249 | AMPK |
PF-249 | ||
PF-06685249 (PF-249) is a potent and orally active allosteric AMPK activator with an EC50 of 12 nM for recombinant AMPK α1β1γ1. PF-06685249 can be used for diabetic nephropathy research. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.